Search Within

Stephanie Gu

Formats
  1. Meeting Abstract (8)
  2. Journal Article (5)
  3. Review (2)
  4. Research Letter (1)
Groups
  1. Department of Medicine (16)
  2. Dermatology (16)
  3. Dermatology Service (16)
  4. Division of Subspecialty Medicine (16)
  5. Survivorship Research (16)
  6. Solid Tumor Oncology Division (10)

More Groups

People
  1. Alina Markova (11)
  2. Mario Lacouture (10)
  3. Stephen Dusza (9)
  4. Andrea Moy (6)
  5. Neil Shah (4)
  6. Lukas Kraehenbuehl (3)

More People

Years
  1. 2025 (1)
  2. 2024 (5)
  3. 2023 (9)
  4. 2022 (1)
Publications
  1. Journal of Clinical Oncology (3)
  2. Journal of the American Academy of Dermatology (3)
  3. Pharmaceuticals (2)
  4. Best Practice and Research: Clinical Haematology (1)
  5. Blood (1)
  6. Breast Cancer Research and Treatment (1)

More Publications

Publishers
  1. Mosby Elsevier (4)
  2. American Society of Clinical Oncology (3)
  3. MDPI (2)
  4. American Association for Cancer Research (1)
  5. American Society of Hematology (1)
  6. Biomed Central Ltd (1)

More Publishers

Results (16)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Effective localized treatment regimen for peristomal pyoderma gangrenosum
    Meeting Abstract

    Nykaza, I.; Gu, S.; Dusza, S.; Norelli, C.; Reynes, R.; Stadler, Z.; Yaeger, R.; Ilson, D.; Markova, A.
    Journal of the American Academy of Dermatology (2025)

    Fulltext@MSK | Save
  • Checkpoint inhibitor-related skin reactions in cancer patients are characterized by unique rash specific immune responses
    Meeting Abstract

    Goleva, E.; Lacouture, M.; Lyubchenko, T.; Gu, S.; Xiao, O.; Kraehenbuehl, L.; Berdyshev, E.; Ketosugbo, K.; Moy, A.; Rotemberg, V.; more...
    Journal of Allergy and Clinical Immunology (2024)

    Fulltext@MSK | Save
  • Dupilumab for the treatment of dermatologic adverse events associated with MEK and EGFR inhibitors
    Meeting Abstract

    Zhang, Z.; Gu, S.; Dusza, S.; Moy, A.; Dunkel, I.; Drilon, A.; Diamond, E.; Lacouture, M.; Markova, A.
    Journal of the American Academy of Dermatology (2024)

    Fulltext@MSK | Save
  • Phototherapy for the treatment of acute and chronic cutaneous graft versus host disease
    Meeting Abstract

    Chen, A.; Gu, S.; Dusza, S.; Harris, A.; Ponce, D.; Markova, A.
    Journal of the American Academy of Dermatology (2024)

    Fulltext@MSK | Save
  • Immunologic profiling of immune-related cutaneous adverse events with checkpoint inhibitors reveals polarized actionable pathways
    Journal Article

    Lacouture, M. E.; Goleva, E.; Shah, N.; Rotemberg, V.; Kraehenbuehl, L.; Ketosugbo, K. F.; Merghoub, T.; Maier, T.; Bang, A.; Gu, S.; more...
    Clinical Cancer Research (2024)

    Fulltext@MSK | Save
  • Pruritus related to trastuzumab and pertuzumab in HER2 + breast cancer patients
    Journal Article

    Gu, S.; Dusza, S.; Quigley, E.; Haliasos, H.; Markova, A.; Marchetti, M.; Moy, A. P.; Dang, C.; Modi, S.; Lake, D.; more...
    Breast Cancer Research and Treatment (2024)

    Fulltext@MSK | Save
  • IL12/23 blockade with ustekinumab as a treatment for immune-related cutaneous adverse events
    Journal Article

    Gu, S. L.; Maier, T.; Moy, A. P.; Dusza, S.; Faleck, D. M.; Shah, N. J.; Lacouture, M. E.
    Pharmaceuticals (2023)

    Fulltext@MSK | Save
  • Safety of immunomodulatory systemic therapies used in the management of immune-related cutaneous adverse events
    Review

    Gu, S. L.; Nath, S.; Markova, A.
    Pharmaceuticals (2023)

    Fulltext@MSK | Save
  • Dermatologic adverse events in acute lymphocytic leukemia patients treated with bispecific T-cell engager blinatumomab
    Research Letter

    Parisi, R.; Cowen, E. A.; Gu, S.; Dusza, S.; Pulitzer, M.; Geyer, M. B.; King, A. C.; Markova, A.
    Leukemia and Lymphoma (2023)

    Fulltext@MSK | Save
  • Ustekinumab for the treatment of immune related cutaneous adverse events (ircAEs)
    Meeting Abstract

    Maier, T.; Gu, S.; Shah, N. J.; Faleck, D. M.; Lacouture, M. E.
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save